Latest Ai And Product Innovation News

ikeGPS Group delivered a strong FY26 with platform subscription revenue up 33% to NZ$19.2 million and positive underlying EBITDA in March, supported by AI-driven pricing and expanding US utility adoption.

Prophecy International has appointed Jonathan Drake as CEO effective July 2026, aiming to strengthen leadership after a period of interim management and strategic recalibration.

REA Group delivered robust Q3 FY26 results, driven by double-digit revenue growth in Australia and record engagement on realestate.com.au, while lowering its cost growth guidance for FY26.

Resmed delivered a robust Q3 FY2026 with 11% revenue growth, margin expansion, and a 21% jump in non-GAAP EPS, while announcing a new U.S. distribution centre and a $0.60 dividend.

Tinybeans Group has reported its inaugural EBITDA-positive quarter with US$8K profit, driven by strong subscription growth, e-commerce expansion, and operational efficiencies following the Qeepsake acquisition.

Freelancer Limited’s 1Q26 saw a 14% rise in group GMV to $263.3 million but a 9.4% revenue drop, weighed down by currency headwinds and security-driven user friction. Escrow.com posted record operating profit, while Loadshift grew revenue and media presence amid operational gains.

Freelancer Limited has delivered a landmark FY25 with record profitability, a major NASA contract win, and significant AI-driven growth across its marketplaces and payment services.

SEEK Limited reported robust H1 FY2026 results, powered by AI-driven product innovation and pricing, delivering strong revenue and profit growth alongside a record interim dividend. However, a significant impairment on its Zhaopin investment weighed on reported earnings.

Adveritas Limited has reported a record $14.25 million annualised recurring revenue for the December 2025 quarter, driven by strong US market growth and AI-enhanced product development. The company’s strategic focus on media agency partnerships and new product lines signals robust momentum ahead.

Prophecy International Holdings reports a modest revenue dip and net loss in FY25, cancels its Complexica merger, and pivots to AI-driven product innovation and cost control.

HeraMED has bolstered its cash position with a $1.98 million capital raise and is on the cusp of finalizing two pivotal U.S. commercial agreements, signaling a major step forward for its digital maternity care platform.

Resonance Health reports robust FY25 results with 29% revenue growth and outlines ambitious FY26 guidance targeting $17 million in revenue and $2 million EBITDA. The company’s transformation into three profit-generating segments underpins its expanding footprint in the global clinical trial ecosystem.